Drug intelligence / Profile preview

Vitree

Development stage: Unknown
Lead developer: New Marketlink Pharmaceutical
Modality: Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration: Oral

Overview

Vitree is a multi-ingredient dietary supplement distributed by New Marketlink Pharmaceutical Corporation in the Philippines. It is formulated as a combination of antioxidants, vitamins, and minerals, specifically containing Vitamin A, Vitamin C, Vitamin E, Zinc, Selenium, Lutein, and Lycopene. The supplement is designed to support eye health and provide systemic antioxidant protection by neutralizing free radicals that cause oxidative stress. It is commonly used to support macular health and overall cellular function, particularly in the context of age-related ocular conditions.

Brand names: Vitree

Beyond the preview

Go deeper on Vitree.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vitree.

Explore the full profile